Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Emergent Biosolutions Inc. (EBS)  
$6.82 0.16 (2.29%) as of 4:30 Fri 6/28


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 53,590,000
Market Cap: 365.48(M)
Last Volume: 10,588,261 Avg Vol: 1,278,549
52 Week Range: $1.5 - $7.91
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NYSE COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  507
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Emergent BioSolutions is a life sciences company focused on providing a portfolio of preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). Co. is focused on products and solutions that address the following five distinct PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives; emerging infectious diseases; travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). Co. has a product portfolio of ten marketed products (vaccines, therapeutics, and drug-device combination products).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 12,919 12,919 12,919 18,361
Total Sell Value $75,830 $75,830 $75,830 $128,186
Total People Sold 1 1 1 2
Total Sell Transactions 3 3 3 6
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1294
  Page 32 of 52  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Chatfield Steven EVP, BioSciences   •       –      –    2013-03-14 4 D $14.46 $14,576 D/D (1,008) 28,000     -
   Abdun-Nabi Daniel CEO & President   •       •      –    2013-03-14 4 D $14.46 $32,506 D/D (2,248) 95,211     -
   El-Hibri Fuad Chairman   •       •       •   2013-03-12 4/A A $0.00 $0 D/D 20,902 1,861,191     -
   El-Hibri Fuad Chairman   •       •       •   2013-03-12 4/A D $14.67 $21,462 D/D (1,463) 1,840,289     -
   Kramer Robert Chief Financial Officer   •       –      –    2013-03-12 4 A $0.00 $0 D/D 3,940 29,311     -
   El-Hibri Fuad Chairman   •       •       •   2013-03-12 4 A $0.00 $0 D/D 20,902 1,860,347     -
   El-Hibri Fuad Chairman   •       •       •   2013-03-12 4 D $14.67 $25,188 D/D (1,717) 1,839,445     -
   Chatfield Steven EVP, BioSciences   •       –      –    2013-03-12 4 A $0.00 $0 D/D 11,939 29,008     -
   Chatfield Steven EVP, BioSciences   •       –      –    2013-03-12 4 D $14.67 $26,890 D/D (1,833) 17,069     -
   Havey Adam SVP, Biodefense Divison   •       –      –    2013-03-12 4 A $0.00 $0 D/D 11,939 31,077     -
   Havey Adam SVP, Biodefense Divison   •       –      –    2013-03-12 4 D $14.67 $12,029 D/D (820) 19,138     -
   Abdun-Nabi Daniel CEO & President   •       •      –    2013-03-12 4 A $0.00 $0 D/D 40,834 97,459     -
   Abdun-Nabi Daniel CEO & President   •       •      –    2013-03-12 4 D $14.67 $46,959 D/D (3,201) 56,625     -
   El-Hibri Fuad Chairman   •       •       •   2013-03-08 4/A D $15.22 $58,110 D/D (3,818) 1,841,752     -
   El-Hibri Fuad Chairman   •       •       •   2013-03-08 4 D $14.46 $62,091 D/D (4,294) 1,856,053     -
   El-Hibri Fuad Chairman   •       •       •   2013-03-08 4 D $15.22 $67,090 D/D (4,408) 1,841,162     -
   Chatfield Steven EVP, BioSciences   •       –      –    2013-03-08 4 D $15.22 $21,825 D/D (1,434) 18,902     -
   Havey Adam SVP, Biodefense Divison   •       –      –    2013-03-08 4 D $15.22 $9,771 D/D (642) 19,958     -
   Abdun-Nabi Daniel CEO & President   •       •      –    2013-03-08 4 D $15.22 $35,067 D/D (2,304) 59,826     -
   Abdun-Nabi Daniel CEO & President   •       •      –    2012-12-27 4 D $15.81 $73,943 D/D (4,677) 62,148     -
   Abdun-Nabi Daniel CEO & President   •       •      –    2012-12-27 4 OE $10.13 $73,949 D/D 7,300 66,825     -
   El-Hibri Fuad Chairman   •       •       •   2012-12-14 4 GA $0.00 $0 I/I 401,006 149,712     -
   El-Hibri Fuad Chairman   •       •       •   2012-12-14 4 GD $0.00 $0 I/I 176,378 127,721     -
   El-Hibri Fuad Chairman   •       •       •   2012-12-12 4 GA $0.00 $0 I/I 304,098 304,098     -
   El-Hibri Fuad Chairman   •       •       •   2012-12-04 4 S $15.08 $649,539 D/D (43,064) 1,845,570     -
  1294 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 32 of 52
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us